ࡱ> svrg .8bjbj 4Dxqbxqb! """8Z\$"N'$$$m&o&o&o&o&o&o&$(+v&u$$$$$&4' $^m& $m& "5#P Nr#Y&'0N' #,$,$,5#$,5#$$$ $$$$$&&$$$N'$$$$$,$$$$$$$$$ B :  SYNAGIS REFERRAL FORM 2021-2022 **FAX COMPLETED FORM TO SYNAGIS REFERRAL PROGRAM at 585-276-2664** BABYS NAME:________________________________DATE OF BIRTH:______________ ADDRESS:___________________________________________________________________ PHONE #s:__________________________ INSURANCE:____________________________POLICY # : __________________________ CARD HOLDER: ________________________RELATION TO BABY:_________________ SECONDARY INS INFO:_______________________________________________________ REFERRING PHYSICIAN:_________________________PHONE:__________________ (1.) Prematurity Patient s Gestational Age: _______wks______days Birth Weight: ____________ Current Weight___________ kg lbs (circle one) Date Recorded __________ ۉ Gestational age of d"28 6/7 weeks and <12 months of age at the start of RSV season (DOB December 1, 2020 or later) ۉ Gestational age of 29 0/7-31 6/7 weeks, <12 months of age at the start of RSV season (DOB December 1, 2020 or later) with a requirement for >21% oxygen for at least the first 28 days after birth NICU HISTORY: ۉ Yes ۉ No Was there a NICU/HOSPITAL dose administered? ۉ Yes; date administered:_________ ۉ No (2.) Diagnosis of chronic pulmonary disease (CLD/BPD), gestational age of 31 6/7 weeks or less, active therapy 6 months before the start of the RSV season ( 6/2021 or later) and DOB 12/1/2019 or later ۉ Yes Is patient receiving medical treatment of (check all that apply & provide the last date received): ۉ Oxygen Date: _________________ ۉ Diuretics Date: __________________ ۉ Corticosteroids Date:___________ (3a) Diagnosis of complex congenital heart disease and/or cyanotic heart disease with DOB 12/1/2020 or later (first year only) ۉ Yes Indicate type of heart problem and ICD-9 diagnosis code: _______________________________________________________________ ۉ Diagnosis of moderate-severe pulmonary hypertension m ۉ Diagnosis of congestive heart failure Cardiac medications: _________________________ Date last received: ________________ Peds Cardiology Only-please indicate MD or NP referring:________________________ (3b) Children <2 years !"$9Z]^bdef    > E d j k x     Թ°~ytotj hk5 hC5 h 5 hQ"5 hUY5 h 5 hcec5 h}5 hm~5 h&5 h8)5 hD5 hG5 hn5h F5CJaJh>,5CJaJh VB5CJaJh(W5CJaJh]5CJaJhm~5CJaJhm5CJaJ jhmhm5CJUaJ)"ef k P ^gdxgdS@&gdSgd&@&gd&gdk@&gd'R,$a$gdm~ $@&a$gd'R, " V   N l    " $ ( ʾ䖇~g~aa~ hzgaJ,hL!B*OJQJ^JfHph"""q h FhSaJh FhSOJQJ^JaJ hSaJhTh h& h Fh& h&aJh Fh&aJhjh&5>*aJh&5>*aJh(Ph&5aJ hC 5aJ h&5aJ hk5 he =5 h 5 hj5&  ( * F L BDHPľIJ妞 h` 5 h)<5h(Ph&5 h"5aJ h-aJhhS5 h$aJ hxaJ hT\aJ hZraJ h]/vaJ hn~aJh FhSOJQJ^JaJhSOJQJ^JaJh FhSaJ h VBaJ hSaJ h|aJ086X4BNt(,--@&gd(Pgd @&gdB@&gd)<gd` gdT\gd F @&^gdso@&gdn~@&gd` ^gd)<gdS`bd "468<@Dƽ|ocWHh Fh OJQJ^JaJhM`OJQJ^JaJhaOJQJ^JaJhn~5OJQJ^JaJhn~h)<5>*aJh|5>*aJh VB5>*aJh(W5>*aJhT\5>*aJh` h` 5>*aJ h` >*h` 5>*aJhn~hn~5>*aJhn~5>*aJhn~h F5>*hn~h05>*hjh05>* h&5>*DFPV\ 4<DHbٵwoaP hW@fhP_CJOJQJ^JaJhT\CJOJQJ^JaJh` CJaJhW@fh^>HCJaJhW@fhCJaJhW@fh FCJaJ hW@fh FCJOJQJ^JaJhT\OJQJ^JaJhP_OJQJ^JaJ h` aJ hsoaJ hPaJ h)<aJh Fh FaJ hT\aJ haJ h aJhn~OJQJ^JaJ(>@BLNTVXhprJN`bȽȯyoeye^W^P^I hx5>* h VB5>* h|5>* h` 5>*hjh^>H5>*hjh e5>*hjhcec5>*hjh F5>*h(Ph&5 hx5 h&5>*h]/vCJOJQJ^JaJh FCJOJQJ^JaJhW@fhCJaJhW@fh FCJaJ hW@fh FCJOJQJ^JaJhT\CJOJQJ^JaJh-CJOJQJ^JaJb&(Ftz|ǵ~s~~bQFhW@fhbCJaJ hW@fh,CJOJQJ^JaJ hW@fhCJOJQJ^JaJh-h-CJaJhW@fh eCJaJh-CJaJhhCJaJhW@fh CJaJ hW@fh CJOJQJ^JaJ h aJ haaJ hPaJ h^>HaJ h,aJh Fh,aJh Fh,OJQJ^JaJ ha5 h)<5 hxh)<hx&(0Bx~,,,,,----$-&--|uke\h(P5>*aJ hT\aJh(Ph(P5aJ h45aJ h(PaJh4hx5>*aJh4OJQJ^JaJh Fh4OJQJ^JaJ h4aJUh45>*aJ hx5aJ hxaJ h_aJhhhUYaJhhhnaJ haJh Fh FaJ hGaJ hnaJ h0aJ! undergoing heart transplantation during RSV season may be considered for prophylaxis ۉ Yes Indicate date of transplant ___________ (4.) Diagnosis of congenital airway abnormality or severe neuromuscular weakness with DOB 12/1/2020 or later, with impaired ability to clear secretions from the upper airway because of ineffective cough Diagnosis:_________________________________ (5.) Children less than 24 months who undergo solid organ or hematopoietic stem cell transplantation and are profoundly immunocompromised during the RSV season (DOB 12/1/2019 or later) Diagnosis:________________________________ (6a) Diagnosis of Cystic Fibrosis with clinical evidence of CLD and/or nutritional compromise (weight for length less than the 10th percentile)with DOB 12/1/2020 or later ۉ Chronic lung disease ۉ Weight for length <10th percentile (6b) Diagnosis of Cystic Fibrosis with manifestations of severe lung disease (previous hospitalization for pulmonary exacerbation in the first year of life or abnormalities on CXR or chest CT) or weight for length < 10th percentile during the second year of life (DOB 12/1/2019 or later) ۉ Chronic lung disease ۉ Weight for length <10th percentile Reference: Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection  HYPERLINK "http://www.pediatrics.org/cgi/doi/10.1542/peds.2014-1665" www.pediatrics.org/cgi/doi/10.1542/peds.2014-1665 m     Revised 6/11/2021 ---. //R0000062D2x222 5 5>5555556777gdB>@&gdT\@&gdR@&gd(P------..... / ///L0P0R0T0Z0l0n0p00000000000ƿ~wp~f\fV h4aJhRh5aJhRh45aJ h>,5aJ h VB5aJhRh` 5aJ h|5aJ hR5aJ h45aJhRh45>*aJ h5aJh4haJ haJ h-5aJhT\haJhT\hT\aJ hT\hT\ hT\aJh VB5>*aJh|5>*aJh` 5>*aJ 01^111111222"24262B2D2H2L2|2222222b3L4~44444455H5J5555߽ߴߙُٙٙٙ{߽ߴٙulf hT\aJhhaJ hMaJhRhR5>*H*aJ hR5aJhRhRH*aJhRhRaJh5>*aJh` 5>*aJh VB5>*aJh|5>*aJh-huH*aJh-huaJ hRaJhR5>*aJhRhu5>*aJhRh-5>*aJ'55566 7n7r7t7777777777777777888$8&8(8*8,8.8żhPghB>h VBhC h3h >jh >U h(PaJh)<h)<aJ hM`aJ hsoaJh/*hT\0JaJjhT\UaJhT\hT\aJ hT\aJhT\hT\5aJ 77777788&8(8*8,8.8@&gdT\gdB> 21h:pU5/ =!"#$% ZNDd N  C *AGCH logoRMG` }FbBs?MDVFMG` }FbBs?JFIF``ExifMM*; JiV >Melone, Amy9494 2018:08:08 12:32:462018:08:08 12:32:46Melone, Amy http://ns.adobe.com/xap/1.0/ 2018-08-08T12:32:46.937Melone, Amy C   '!%"."%()+,+ /3/*2'*+*C  *o" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?F((((((((((((((((((((((((((((((( X̗3G #wwxQN ͍rykƠN_Mu׈pVb2NNX*mݯծRz$/|9iqyB_;E`qC*+IAҼ )dk #F ^!ⶀKcW`o ;55'e%{̎y̶CSo$l/m~bW|)8߉4^F&~V8`eW r#Vرеt< hӬPh{!R?^]%qFZ~kiwRcC: ]Yǥj 6w2ȱp{kĖZvnSdIN@Rx'WKiTƫ]i.5P)8W IC* _D5le@vc s_ i:]xEɵf!9xM3b%Ek& .T̪vqRU'E4!iXe9) zdjr;_C^ڑsߴM[wA(м裫4j c@|Al-:54agSOcM&o%#xSV*x?*ӄ*N3QKs[QI/ynU \fO >/_Ҹܨ.`(*÷#^;ˆ<]{ePYHPg'!:xªmϣY#rj6èiԖ۔XV#5 xkKsjq\ojh^hfh"cU^N#5!Jo|Nuck'{ ?>'_:g7 t!6w2Td snJTg"֍hsD*޵ac]/53lcyk3گW +ZqRv}UI8v;(4 ipyڝ_߸c_̚/?G{ ZIw\U':rx%٬F5v[# G;czۻ94)~c@ Zɴ8~.4jBp#u|?j pBA*"|OmŶoau3j{6-D:+̾A{^ {5Yy16Ax5鴪CVN|QEfhQEQEQEQEQEQEQEQEQEQEQEQEQEQES? y\HbtܨxT]Jz8I$mB@JGX-pkH5Ss3,fHy(Һ=N=jr}Cn*wۢ{<:(gK8"^9<nة|Im-`ɴV2T}{ "4GcivK8a/!-NGJY"gFZ,~ >STնI%)sk>xVOX{"262 ~ OVq{?Ȯ.'E$n130zdx#z|-XGҹ5@̟{\>k/dG'dY@6+3ߥ^3NJ}-3y^nJuKV'h"S5Fir^'xoLKm-RHzqo[FirMNm|-6/I=i~=^EiJ}u_%i~6Yƹ*!Evִ͎QEyE`1Q^^ucBNMQ2kzßхOCL$^Sy#^Qk>!7xKozԺ//dHEY,QYoS1:o 4t͡,x)'r?JK]N>x-]ʰ{g;EdJeH> -|Lv-YL'>V:Vٲ'7g|񧊼âqޤjo3A=_Gq! utWz&>xn;+"͜Au"[7~ o֚|Aȳ s&TboI+*ٵs )ʤԥ{;W#[B{]6͵-jofd@͇Ѽ6.6\7χ?hյdfkyWU%G_B_ZVQ^i̻& >EQWAӓ9gk~%׾1WWN& 8Z6é[.̾qt=X)|?ˆ)~ƽڝ1. ND @zaxǾ*īts\2B.9Fe 癏yҳo_4KOjͨj1Z»I'k?ȷm곾tԾϗ+t$q$4ѴǾݳܳ+<_{{{n忼 kqpuJqR]B(({Ru'Qɹ88d\zU3 {[4. )$'u>.4^Hd"hmՙZV?0%k:ޫ-޴lm t. vO!_ ߏPrJ+wMt(Ɯm/tF@dt4\${""+*. j}j_2B?0|=yƯ Ylt{u_`<}ѴZBa")("ml<Qi+ݟ-̒Wh[t]SG0Yh[:y0w6˞63jw6q :0e/(2FY矛\R{]_^_zzFfQr~pzMT˻]9wBf@=F?NEEKz+]-u1TߗQMymo5 ,yF4$ }kr [/U\ lxd0Xu tDI$*H-2x&[/<5tZTZ$eV|=ԣ&+Ӳ[YY[RQyZ_M{5koðKffC ev6 1^CߍoO9 o> RXˣ.ҭdzọDzꑣ MOG ,\*J61?e>?6`%_R +ϔ\$-F2Sv ߅gw0ԗ]λ2Gu^ja u1Xۯ/,ԁ"e9#Zݤe/zK߉r̸$ٺq?j-z'XkoXgwQMI HD]t&rVz&<9w_&&6=?j_ #f6i)Oz׌0 ڼ㧁nMh!FMҞ̼e&ҫ zݥpJ: #z2*#o%o1:|p'&"}##Z7tѬAIp*腮o\BG~a[^Gs^?Di2\kK#~5G[5JS}f7#(SSJn5xgGv@uxckVEy2$NvH8KCݎ=[o3\TR;Њvg6 쥺/ד|[z?|I:}RN^ɲ@ڽf/rjlVy5V)uhE:Rog| [xXյ+7if'7sկC<;X߻j!ַ6'k~0xB%2_iQFLdrrwC9[/|*9m z?5׆|P,eHf.q׍^\XnZgn$W˺uלa|ӑ ¾uk] E5 okϮ:N5|=wxQbWIz +|+9c R-s$PŪ?_)W~7>@Ё?Ws0?Ȋ/(4?"P)h.>w=&ұ<7[t%f5oĉQ?h8]b;"!Uv⿇OEse9k)8#Gnm/FH5t =qھ,]Ouf =HFO|zӵC ԭ$]@E+]TȢyS~ʢ #Q{Zn̛-gG鄨'dб|rc^𾡫ύ? ~5㿳~ׯc?eߖ? M]>4-ƾ.b;"t#E˰^éz9ݴIܵ<$zx=x_U+=6W(#tF m;W*T* J#_K +sg9aRa^S|ssO0`\~߇$*63y 0&>돕Sip UQ}JYf( KI+FxkXAH5I 66Hxd xf[=DJ _4Khfuúb:[STOtcRN6ѭXx sqw6hz\.~h >|WjV~!9g1E>T'pyH_o+T9A}΅gRդxXhUkSyWUw xkk;dgdH=r}+|?xjSe s<'u>ǨV5ˍj(i-E0NJcH VT3M- aQSMjvxJ#U%s? \~'&tVWExK&ݜwvWR9WZ|-u .R dԐo*?PTiYmta7ws[QmUT>dsau+#KĂ4l zq[,U^8<JZݼa1(cP@ܴuMud\Lx\<70IJG&WiVD\n#i$~LTK[m$z,y&I&:g]%ywkq.{(K+Fxb . qӯc>"Z֥Qn`Erݼ9hJܦ~#VbgoJ%4ѵ2HW1wa|FkcGhh0ܼ&;d3}|#wZ={jgG˞XX#//8q׌V]OS ekwj.*(b@P;.y$F-N'c8Ɯ.W1oK''4!#s1KK{h$q Q^}_[E%ŬZWmY-`lL:pWPZxZi%;{ÒHIav?L)¤WV*ݝ ,9dˡ#8>"jV:Գݷ62~봳9#<~#]V=ăLѧӍ1Yvu9L+[֏1~]5O Mm$$ LGlcڟ>^ S{HRvn~\pgwx~i.겼J};+/pGL`<{}G>gIV6p9 gFֿoCOWwZ7ĺ޵6x[;!eJ? ZmR~p? + 7^+ЏG{8l_7O Td[i9m"=RH)Ɲ:i᷊ O 0kv9*mG?;dx}>v󭖡\R vj5EejKYha󪻖|hqxI:|jW*$SG>OmMյ;* P>QN1]q>:Εkڎfg6Ѩ.xRWoujN%摁28ݞۚƤ'9IiR\񯃬|m4H{h_zwxr^ ѵ kw戝i2c> a"=vݷ8>T0PoG)ЩiV:ޛ6%ͬ~]e/^"%Xta^EM:ӦUJ0G |T! V# p G^O+]3]Ms]t :۰QOJGK-m(((yeCsȌ0C ח 􋗾m6紓O_* +zg();^_Hmw~ڌ!AzW xZ-ܼ9'tBRZqbT曻 (}ip[ cג(J6g%qZkg③Ifk:eI@ڧ1*bRhΌf#Gk ,|0GwGi4ܰɺُҡm~&'KY8larF8{E?X4vw1r5#?cߡ1R;:Qjũ˥Чtx>[6 g5Oh2ռIu шݚ$*Q@mE(qTII0e_Ҵ{&KQO<IrڧuK%Zm=nac، 6'ڽq($GreJ3mxSú֟wkk %\ *N7( 8"= [zM7_+ZCKIPdleW`9ʊ~VZujZ%v4_d[,g9,n{[Ǫ%:][ƛN'j2eFmQYQ@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@s02 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@_HmH nH sH tH @`@ SNormalCJ_HaJmH sH tH @@  F Heading 1@& B*^JphDA D Default Paragraph FontRiR  Table Normal4 l4a (k (No List b/b FDefault 7$8$H$-B*CJOJQJ^J_HaJmH phsH tH @P@  F Body Text 2 B*^Jph@Q@  F Body Text 3 B*^JphJCJ  FBody Text Indent B*^JphH2H z Balloon TextCJOJQJ^JaJZYBZ 'R, Document Map-D M CJOJQJ^JaJ4R4 B>Header  H$6/a6 B> Header CharCJaJ4 @r4 B>0Footer  H$6/6 B>0 Footer CharCJaJ6U`6 C Hyperlink >*B*phFV F C FollowedHyperlink >*B*phPK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭Vc:E3v@P~Ds |w< D # Db-05.8  -7.8 !rX@ @H 0(  0(  B S  ?z} qs(*mp  ILkr ^ k c e L N  ' . 3333333333333333333333333!Z]^bEE TWfh STsu"DMy|%' X Z Z * - 6 8     # $ = > @ d L !Z]^bEE TWfh STsu"DMy|%' X Z Z * - 6 8     # $ = > @ d L k{.Xh^`OJQJo(hHh^`OJQJ^Jo(hHoh  ^ `OJQJo(hHh\ \ ^\ `OJQJo(hHh,,^,`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohll^l`OJQJo(hHk{          I]4,1,S ;0v'Gj0y uUYRz}gB2xx@_0 ` #!L!Q"$[|$W%&a&8)\A)g|*,>,FC,'R,[.R0R1{2e =;=!==D= >B>~>R@F@PB VBDQE=FW8G^>HXHISJhK MNNKN(P0PpQxST(WT\y]_P_b3ccec)eW@fPgzg~i"j{0km?yorWirs \s^s]/vwvyq#y}Zyhn~ P'Zl3m#x]n m~)<so[bE% cMES_ (Ek m{PU5.P e>:#9P ec L9QNLOCZr Fzd-*E]l>,|FaM`E6AC ~C 3ZwC"-j~0:44`io4FJ@UROy@p @ ,UnknownG.[x Times New Roman5Symbol3. .[x Arial5. .[`)Tahoma?= .Cx Courier New;WingdingsA$BCambria Math"qhZ#gI; ; !24 3QHP ? F2!xxB CLINICAL INFORMATIONmjplatt Melone, Amy Oh+'0  0 < H T`hpxCLINICAL INFORMATIONmjplattNormal Melone, Amy3Microsoft Office Word@F#@O ߣ@ /^@t.M;  ՜.+,D՜.+,L hp  Strong Health CLINICAL INFORMATION Title 8@ _PID_HLINKSA9http://www.pediatrics.org/cgi/doi/10.1542/peds.2014-1665  !"$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJLMNOPQRSTUVWXYZ[\]^_`acdefghiklmnopqtuxRoot Entry F| Nw@Data #ZN1TableK4,WordDocument 4DSummaryInformation(bDocumentSummaryInformation8jMsoDataStoreK NP NMVKDJ4HA3OCGSQ==2K NP NItem  PropertiesUCompObj r   F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q